Provider

Dr. Harm Scherpbier, HealthShare Exchange CMIO, describes how the company's platform connects practices, payers and ACOs, allowing them to share patients’ data in real time across facilities to coordinate care seamlessly.  

Ran Balicer, HIMSS board of directors member, talks about the possibility of clinical digital support technology to personalize care by helping clinicians predict potential health issues for patients so they can be prevented.  

The company is now an in-network provider with numerous insurers and commercial and Medicare Advantage plans, expanding its reach to all 50 states.

Tx-LLM was fine-tuned from Google's Med-PaLM 2 and created to analyze a variety of chemical or biological entities to assist with the drug-discovery pipeline.

In part one of a two-part series, Dr. Bruce Darrow, Mount Sinai Health System CMIO and interim CDIO, relays how patients may gain confidence in relying on AI instead of doctors as accuracy of pattern recognition and predictive models improve.  

Aaron Gani, CEO and founder of RealizedCare, discusses the evolution of digital therapeutics, the FDA’s place in advancing them, keeping up with evolving technology, and the benefits of DTx modalities for the pharmaceutical industry.  

The telemedicine company's clinical president and its founder and CEO allegedly participated in a scheme to profit from providing easy access to Adderall for no valid medical purpose.

Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses the definition of a digital therapeutic, companies in the DTx space, why the organization held its recent summit in D.C. and the status of the Prescription Digital Therapeutics Act.  

Dave Bailey, VP, Consulting Services at Clearwater Security, recommends developing cybersecurity strategy around a framework like NIST 2.0 and working with leadership to get the necessary resources to address vulnerabilities.  

The company will use the funds to expand its team.